Document is current
Any future updates will be listed below
-
Authors
Reignier, Jean https://orcid.org/0000-0002-3768-3496
Gaillard-Le Roux, Benedicte
Dequin, Pierre François
Bertoni Maluf, Valeria A.
Bohe, Julien
Casaer, Michael P.
Delbove, Agathe
Dupuis, Claire
Fontaine, Eric
Gamon, Prescillia
Grange, Coralie
Heming, Nicholas
Jezequel, Melissa
Jirka, Adam
Jotterand Chaparro, Corinne
Landais, Michael
Letouze, Nolwenn
Morice, Claire
Pantet, Olivier
Pellecer, Julie
Piton, Gael
Rooze, Shancy
Starck, Julie
Tadie, Jean-Marc
Tamion, Fabienne
Thibault, Ronan
Valla, Frédéric
Vanderlinden, Thierry
Thille, Arnaud W.
Aissaoui, Nadia
- License Information
-
More Information
Article History
Received: 16 May 2025
Accepted: 23 June 2025
First Online: 15 July 2025
Declarations
:
: Not applicable.
: Not applicable.
: JR: funding from research programs run by the French Ministry of Health (NUTRIREA-2, NUTRIREA-3 and NUTRIREA-4 trials). BGLR: consulting fees from Fresenius. PFD: funding from research programs run by the French Ministry of Health, equipment loans from Aerogen and Fisher and Paykel, consulting fees from Aridis Pharmaceuticals. EF: consulting and training services fees from Baxter, Nutricia, Fresenius, Aguettant and BBraun. RT: consulting fees from Baxter, Fresenius-Kabi and Nutricia; writing reports or patient tools for Aguettant, Boehringer Ingelheim and Roche; speaker at symposia or scientific meetings organized by Astra-Zeneca, Baxter, BBraun, Fresenius-Kabi, Lactalis, Nestlé, Novonordisk, Nutricia, or Shire; fees for the design of the SEFI® (KNoë-Groupe Get, Le Kremlin Bicêtre, France). FV: consulting fees from Baxter, Nutricia and Nestle Health Science. TV: consulting and training fees from Baxter and Nutricia; travel expense for congress: Nestlé, Sysmed and Homeperf. The remaining authors declare no conflict of interest.
